Bone structural components regulating sites of tumor metastasis

Current Osteoporosis Reports

Volumn 9, Issue 2, 2011, Pages 89-95

  Sterling, Julie A ^a,b,c   Guelcher, Scott A ^c,d  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^d VANDERBILT UNIVERSITY   (United States)

Author keywords

Bone metastasis; Breast cancer; Mechanotransduction; Rigidity; ROCK; TGF

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; ANTINEOPLASTIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; DENOSUMAB; FASUDIL; RHO KINASE; SD 208; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; BONE DESTRUCTION; BONE METASTASIS; BONE STRUCTURE; BRAIN VASOSPASM; BREAST CANCER; CANCER CELL; CANCER GROWTH; CARCINOGENESIS; CELL INVASION; DRUG EFFICACY; DRUG SAFETY; FEMUR SUBTROCHANTERIC FRACTURE; FRACTURE; GENE EXPRESSION; HEART DISEASE; HUMAN; HYPOCALCEMIA; JAW OSTEONECROSIS; LUNG CANCER; LUNG DISEASE; NONHUMAN; OSTEOPOROSIS; PHARMACOLOGICAL BLOCKING; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN SECRETION; PULMONARY HYPERTENSION; RIGIDITY; RISK ASSESSMENT; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT;

ANTIBODIES, MONOCLONAL; BONE DENSITY CONSERVATION AGENTS; BONE NEOPLASMS; BREAST NEOPLASMS; DIPHOSPHONATES; FEMALE; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MALE; NUCLEAR PROTEINS; PARATHYROID HORMONE-RELATED PROTEIN; RANK LIGAND; RHO-ASSOCIATED KINASES; TRANSFORMING GROWTH FACTOR BETA;

EID: 79957521370     PISSN: 15441873     EISSN: 15442241     Source Type: Journal    
DOI: 10.1007/s11914-011-0052-5     Document Type: Article

References (50)

1. T Guise J Yin S Taylor Y Kumagai M Dallas B Boyce, et al. 1996 Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis J Clin Invest 98 1544 9 8833902 10.1172/JCI118947 1:CAS:528:DyaK28XmtVCmu70%3D (Pubitemid 26327863)
2. MR Smith 2005 Zoledronic acid to prevent skeletal complications in cancer: corroborating the evidence Cancer Treat Rev 31 Suppl 3 19 25 16229955 10.1016/j.ctrv.2005.09.004 (Pubitemid 41763529)
3. V Stresing F Daubine I Benzaid H Monkkonen P Clezardin 2007 Bisphosphonates in cancer therapy Cancer Lett 257 16 35 17697748 10.1016/j.canlet.2007.07.007 1:CAS:528:DC%2BD2sXhtFSnt7vP (Pubitemid 47464698)
4. F Daubine C Le Gall J Gasser J Green P Clezardin 2007 Antitumor effects of clinical dosing regimens of bisphosphonates in experimental breast cancer bone metastasis J Natl Cancer Inst 99 322 30 17312309 10.1093/jnci/djk054 1:CAS:528:DC%2BD2sXjsVeitrc%3D (Pubitemid 47073494)
5. RE Coleman A Lipton GD Roodman TA Guise BF Boyce AM Brufsky, et al. 2010 Metastasis and bone loss: advancing treatment and prevention Cancer Treat Rev 36 615 20 20478658 10.1016/j.ctrv.2010.04.003
6. JA Sterling JR Edwards TJ Martin GR Mundy 2011 Advances in the biology of bone metastasis: how the skeleton affects tumor behavior Bone 48 6 15 20643235 10.1016/j.bone.2010.07.015 1:CAS:528:DC%2BC3cXhs1Wgu7rL
7. JJ Yin K Selander JM Chirgwin M Dallas BG Grubbs R Wieser, et al. 1999 TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development J Clin Invest 103 197 206 9916131 10.1172/JCI3523 1:CAS:528:DyaK1MXltFeqsQ%3D%3D (Pubitemid 29053137)
8. J Southby MW Kissin JA Danks JA Hayman JM Moseley MA Henderson, et al. 1990 Immunohistochemical localization of parathyroid hormone-related protein in human breast cancer Cancer Res 50 7710 6 2253214 1:STN:280: DyaK3M%2FntVGhtw%3D%3D
9. GJ Powell J Southby JA Danks RG Stillwell JA Hayman MA Henderson, et al. 1991 Localization of parathyroid hormone-related protein in breast cancer metastases: increased incidence in bone compared with other sites Cancer Res 51 3059061
10. MA Henderson JA Danks JL Slavin GB Byrnes PF Choong JB Spillane, et al. 2006 Parathyroid hormone-related protein localization in breast cancers predict improved prognosis Cancer Res 66 2250 6 16489028 10.1158/0008-5472.CAN-05-2814 1:CAS:528:DC%2BD28XhsFals7k%3D
11. CJ Pirola HM Wang MI Strgacich A Kamyar B Cercek JS Forrester, et al. 1994 Mechanical stimuli induce vascular parathyroid hormone-related protein gene expression in vivo and in vitro Endocrinology 134 2230 6 8156926 10.1210/en.134.5.2230 1:CAS:528:DyaK2cXivFSmsrc%3D (Pubitemid 24142967)
12. M Yamamoto SC Harm WA Grasser MA Thiede 1992 Parathyroid hormone-related protein in the rat urinary bladder: a smooth muscle relaxant produced locally in response to mechanical stretch Proc Natl Acad Sci USA 89 5326 30 1376916 10.1073/pnas.89.12.5326 1:CAS:528:DyaK38XksVWjsr4%3D
13. WM Philbrick JJ Wysolmerski S Galbraith E Holt JJ Orloff KH Yang, et al. 1996 Defining the roles of parathyroid hormone-related protein in normal physiology Physiol Rev 76 127 73 8592727 1:CAS:528:DyaK28XisFynsLg%3D (Pubitemid 26048280)
14. MJ Paszek N Zahir KR Johnson JN Lakins GI Rozenberg A Gefen, et al. 2005 Tensional homeostasis and the malignant phenotype Cancer Cell 8 241 54 16169468 10.1016/j.ccr.2005.08.010 1:CAS:528:DC%2BD2MXhtV2gt7vO (Pubitemid 41317594)
15. MJ Paszek VM Weaver 2004 The tension mounts: mechanics meets morphogenesis and malignancy J Mammary Gland Biol Neoplasia 9 325 42 15838603 10.1007/s10911-004-1404-x (Pubitemid 41149140)
16. B Geiger A Bershaksky 2002 Exploring the neighborhood: adhesion-coupled cell mechanotransducers Cell 110 139 43 12150922 10.1016/S0092-8674(02)00831-0 1:CAS:528:DC%2BD38XlvV2hsbk%3D (Pubitemid 34876542)
17. AJ Galliher WP Schiemann 2006 Beta3 integrin and Src facilitate transforming growth factor-beta mediated induction of epithelial-mesenchymal transition in mammary epithelial cells Breast Cancer Res 8 4 R42 16859511 10.1186/bcr1524 (Pubitemid 44219657)
18. EG Arias-Salgado S Lizano S Sarkar JS Brugge MH Ginsberg SJ Shattil 2003 Src kinase activation by direct interaction with the integrin beta cytoplasmic domain Proc Natl Acad Sci USA 100 13298 302 14593208 10.1073/pnas.2336149100 1:CAS:528:DC%2BD3sXptFOis7o%3D (Pubitemid 37444736)
19. DT Butcher T Alliston VM Weaver 2009 A tense situation: forcing tumour progression Nat Rev Cancer 9 108 22 19165226 10.1038/nrc2544 1:CAS:528:DC%2BD1MXpsVeqtA%3D%3D This review highlights the role of mechanical forces in the invasion and progression of breast tumors
20. JS Desgrosellier DA Cheresh 2010 Integrins in cancer: biological implications and therapeutic opportunities Nat Rev Cancer 10 9 22 20029421 10.1038/nrc2748 1:CAS:528:DC%2BD1MXhsF2hsLzI
21. AJ Galliher WP Schiemann 2007 Src phosphorylates Tyr284 in TGF-beta type II receptor and regulates TGF-beta stimulation of p38 MAPK during breast cancer cell proliferation and invasion Cancer Res 67 3752 8 17440088 10.1158/0008-5472.CAN-06-3851 1:CAS:528:DC%2BD2sXkt1Kitro%3D (Pubitemid 46762161)
22. JG Schneider SR Amend KN Weilbaecher 2011 Integrins and bone metastasis: integrating tumor cell and stromal cell interactions Bone 48 54 65 20850578 10.1016/j.bone.2010.09.016 1:CAS:528:DC%2BC3cXhs1Wgu7rJ
23. SW Moore P Roca-Cusachs MP Sheetz 2010 Stretchy proteins on stretchy substrates: the important elements of integrin-mediated rigidity sensing Dev Cell 19 194 206 20708583 10.1016/j.devcel.2010.07.018 1:CAS:528: DC%2BC3cXhtVejs73E
24. S Kumar VM Weaver 2009 Mechanics, malignancy, and metastasis: the force journey of a tumor cell Cancer Metastasis Rev 28 113 27 19153673 10.1007/s10555-008-9173-4
25. AV Bakin C Rinehart AK Tomlinson CL Arteaga 2002 p38 mitogen-activated protein kinase is required for TGFbeta-mediated fibroblastic transdifferentiation and cell migration J Cell Sci 115 3193 206 12118074 1:CAS:528:DC%2BD38XmsFarsr4%3D
26. CB Khatiwala PD Kim SR Peyton AJ Putnam 2009 ECM compliance regulates osteogenesis by influencing MAPK signaling downstream of RhoA and ROCK J Bone Miner Res 24 886 98 19113908 10.1359/jbmr.081240 1:CAS:528:DC%2BD1MXlvVWhtbk%3D This study demonstrates that osteoblast differentiation is regulated by the rigidity of the extracellular matrix in bone through ROCK, and that blocking ROCK delays differentiation
27. S Liu RH Goldstein EM Scepansky M Rosenblatt 2009 Inhibition of rho-associated kinase signaling prevents breast cancer metastasis to human bone Cancer Res 69 8742 51 19887617 10.1158/0008-5472.CAN-09-1541 1:CAS:528:DC%2BD1MXhtl2rtr7P This study demonstrates that molecular or pharmacologic inhibition of ROCK blocks metastasis of breast tumors to bone, and overexpression of ROCK confers a metastatic phenotype to a non-metastatic cell line. It is also suggested that inhibition of ROCK could represent a novel therapy for treatment of breast cancer metastases
28. A Kostic CD Lynch MP Sheetz 2009 Differential matrix rigidity response in breast cancer cell lines correlates with the tissue tropism PLoS ONE 4 e6361 19626122 10.1371/journal.pone.0006361 This study demonstrates that SCPs derived from MDA-MB-231 cells showed increased migration to proliferation when cultured on matrices with rigidities corresponding to the native rigidities of the organs where metastasis was observed. Thus, SCPs targeted specifically to bone proliferated faster and were more invasive on rigid tissue culture polystyrene compared with soft PAA gels
29. NS Ruppender AR Merkel TJ Martin GR Mundy JA Sterling SA Guelcher 2010 Matrix rigidity induces osteolytic gene expression of metastatic breast cancer cells PLoS ONE 5 e15451 21085597 10.1371/journal.pone.0015451 This study demonstrates that osteolytic breast and lung tumor cells cultured on substrates with rigidities comparable to that of mineralized bone tissue show increased expression of Gli2 and PTHrP compared with cells cultured on soft substrates. Furthermore, both ROCK and TGF-β are required for the increased PTHrP expression on rigid substrates
30. MH Zaman LM Trapani A Sieminski D MacKellar H Gong RD Kamm, et al. 2006 Migration of tumor cells in 3D matrices is governed by matrix stiffness along with cell-matrix adhesion and proteolysis PNAS 103 10889 94 16832052 10.1073/pnas.0604460103 1:CAS:528:DC%2BD28XnsFensrg%3D (Pubitemid 44148391)
31. NR Alexander KM Branch IC Iwueke SA Guelcher AM Weaver 2008 Extracellular matrix rigidity promotes invadopodia activity Curr Biol 18 1295 9 18718759 10.1016/j.cub.2008.07.090 1:CAS:528:DC%2BD1cXhtVykurrJ
32. AJ Engler S Sen HL Sweeney DE Discher 2006 Matrix elasticity directs stem cell lineage specification Cell 126 677 89 16923388 10.1016/j.cell.2006.06.044 1:CAS:528:DC%2BD28Xpt1aktbg%3D (Pubitemid 44233625)
33. SA Guelcher J Dumas A Srinivasan JE Didier JO Hollinger 2008 Synthesis, mechanical properties, biocompatibility, and biodegradation of polyurethane networks from lysine polyisocyanates Biomaterials 29 1762 75 18255140 10.1016/j.biomaterials.2007.12.046 1:CAS:528:DC%2BD1cXis1Wmsr8%3D
34. Gibson LJ, Ashby MF. Cellular solids: structure and properties. Cambridge: Cambridge University Press; 1997.
35. Y Kang PM Siegel W Shu M Drobnjak SM Kakonen C Cordo'n-Cardo, et al. 2003 A multigenic program mediating breast cancer metastasis to bone Cancer Cell 3 537 49 12842083 10.1016/S1535-6108(03)00132-6 1:CAS:528:DC%2BD3sXltlSmsL4%3D (Pubitemid 36808649)
36. DE Discher P Janmey YL Wang 2005 Tissue cells feel and respond to the stiffness of their substrate Science 310 1139 43 16293750 10.1126/science. 1116995 1:CAS:528:DC%2BD2MXht1WgtLbF (Pubitemid 41681732)
37. GR Mundy 1997 Mechanisms of bone metastasis Cancer 80 1546 56 9362421 10.1002/(SICI)1097-0142(19971015)80:8+<1546::AID-CNCR4>3.0.CO;2-I 1:STN:280:DyaK1c%2Fis1Ontg%3D%3D (Pubitemid 27444026)
38. SM Kakonen KS Selander JM Chirgwin JJ Yin S Burns WA Rankin, et al. 2002 Transforming growth factor-beta stimulates parathyroid hormone-related protein and osteolytic metastases via Smad and mitogen-activated protein kinase signaling pathways J Biol Chem 277 24571 8 11964407 10.1074/jbc.M202561200 1:CAS:528:DC%2BD38XltlOht7s%3D (Pubitemid 34951984)
39. T Kita Y Hata R Arita S Kawahara M Miura S Nakao, et al. 2008 Role of TGF-beta in proliferative vitreoretinal diseases and ROCK as a therapeutic target Proc Natl Acad Sci USA 105 17504 9 18952846 10.1073/pnas.0804054105 1:CAS:528:DC%2BD1cXhsVWntrzE This study elucidates the critical role of TGF-β in mediating cicatricial contraction in proliferative vitreoretinal diseases. ROCK, a key downstream mediator of TGF-β and other factors, might become a unique therapeutic target in the treatment of proliferative vitreoretinal diseases
40. AK Kamaraju AB Roberts 2005 Role of Rho/ROCK and p38 MAP kinase pathways in transforming growth factor-beta-mediated Smad-dependent growth inhibition of human breast carcinoma cells in vivo J Biol Chem 280 1024 36 15520018 10.1074/jbc.M403960200 1:CAS:528:DC%2BD2MXitFChsQ%3D%3D
41. E Shane 2010 Evolving data about subtrochanteric fractures and bisphosphonates N Engl J Med 362 1825 7 20335574 10.1056/NEJMe1003064 1:CAS:528:DC%2BC3cXmtVKgtb0%3D Bisphosphonates, the major class of drugs used to treat osteoporosis, decrease osteoclast-mediated bone resorption and bone turnover markers and increase bone mineral density. They have been shown to be safe and reduce the risk of osteoporotic fractures
42. MR McClung 2006 Inhibition of RANKL as a treatment for osteoporosis: preclinical and early clinical studies Curr Osteoporos Rep 4 28 33 16527005 10.1007/s11914-006-0012-7 (Pubitemid 44623945)
43. A Lipton GG Steger J Figueroa C Alvarado P Solal-Celigny JJ Body, et al. 2008 Extended efficacy and safety of denosumab in breast cancer patients with bone metastases not receiving prior bisphosphonate therapy Clin Cancer Res 14 6690 6 18927312 10.1158/1078-0432.CCR-07-5234 1:CAS:528:DC%2BD1cXht1Kgur3M
44. E Gonzalez-Suarez AP Jacob J Jones R Miller MP Roudier-Meyer R Erwert, et al. 2010 RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis Nature 468 103 7 20881963 10.1038/nature09495 1:CAS:528:DC%2BC3cXht1ajur7J
45. V Ganapathy R Ge A Grazioli W Xie W Banach-Petrosky Y Kang, et al. 2010 Targeting the transforming growth factor-beta pathway inhibits human basal-like breast cancer metastasis Mol Cancer 9 122 20504320 10.1186/1476-4598-9-122 This study shows that TGF-β plays an important role in both bone and lung metastases of breast cancer. Furthermore, inhibiting TGF-β signaling shows a therapeutic effect that is independent of the tissue tropism of the metastatic tumor cells. Targeting TGF-β signaling is a potentially useful therapeutic approach for treating metastatic basal-like breast cancer
46. KS Mohammad D Javelaud PG Fournier M Niewolna CR McKenna XH Peng, et al. 2011 The transforming growth factor-{beta} receptor I kinase inhibitor SD-208 reduces the development and progression of melanoma bone metastases Cancer Res 71 175 84 21084275 10.1158/0008-5472.CAN-10-2651 1:CAS:528:DC%2BC3MXovFKl This study demonstrates that therapeutic targeting of TGF-β may prevent the development of melanoma bone metastases and decrease the progression of established osteolytic lesions
47. JR Edwards JS Nyman ST Lwin MM Moore J Esparza EC O'Quinn, et al. 2010 Inhibition of TGF-β signaling by 1D11 antibody treatment increases bone mass and quality in vivo J Bone Miner Res 25 2419 26 20499365 10.1002/jbmr.139 1:CAS:528:DC%2BC3cXhsVOjtbzK This study demonstrates that blocking TGF-β with 1D11 increases the population of osteoblasts and decreases the population of active osteoclasts in the marrow, significantly increasing bone volume and quality
48. AR Tan G Alexe M Reiss 2009 Transforming growth factor-beta signaling: emerging stem cell target in metastatic breast cancer? Breast Cancer Res Treat 115 453 95 18841463 10.1007/s10549-008-0184-1 1:CAS:528:DC%2BD1MXmsVCrtLg%3D This study demonstrates that in genetic mouse models in which TGF-β signaling is stimulated, TGF-β inhibits formation of mammary tumors at early stages, but can promote metastasis of tumors at later stages. These observations suggest that although TGF-β inhibitors may block bone resorption in patients with bone metastases, they could possibly increase tumor cell growth in the primary site
49. SA Barman S Zhu RE White 2009 RhoA/Rho-kinase signaling: a therapeutic target in pulmonary hypertension Vasc Health Risk Manag 5 663 71 19707285 10.2147/VHRM.S4711 1:CAS:528:DC%2BD1MXhtVyltrfL This paper reviews the extensive animal studies reporting that increased RhoA/ROCK signaling is important in the pathogenesis of pulmonary hypertension by stimulating enhanced construction and remodeling of the pulmonary vasculature. Both preclinical and clinical studies suggest that ROCK inhibitors are effective for treatment of severe pulmonary arterial hypertension (PAH) with minimal safety risk, which underscores the potential of ROCK inhibitors as a new class of drugs for treatment of PAH
50. MF Olson 2008 Applications for ROCK kinase inhibition Curr Opin Cell Biol 20 242 8 18282695 10.1016/j.ceb.2008.01.002 1:CAS:528:DC%2BD1cXks1Gnu7Y%3D